◀ Back to BCR
BCR — POLDIP2
Text-mined interactions from Literome
Swart et al., J Immunol 2000
(Lymphoma, B-Cell...) :
The activity of
p38 mitogen activated protein kinase ( MAPK ) was increased in
response to
BCR ligation
Swart et al., Biochem Biophys Res Commun 2000
:
By contrast, we show that pretreatment of CH31 B cells with the highly specific p38 MAPK inhibitor SB203580 ablated both
BCR induced
p38 MAPK activity and apoptosis
Wu et al., J Immunol 2001
(Severe Combined Immunodeficiency) :
Thus, CD72 and
BCR activated the extracellular signal regulated kinase ( ERK ) and the c-Jun N-terminal kinase (JNK) but not
p38 mitogen activated protein kinase
Niiro et al., J Exp Med 2002
(Calcium Signaling) :
Moreover,
BCR induced
activation of extracellular signal regulated kinase ( ERK ), c-jun NH2-terminal kinase ( JNK ), and
p38 mitogen activated protein kinase ( MAPK ) pathways was impaired in Bam32 ( -/- ) cells but not the activation of Akt related pathways
Lee et al., Journal of cell communication and signaling 2007
:
In contrast,
BCR induced activation of ERK, JNK,
p38 , and Akt was not affected by ROS depletion
Ha et al., J Leukoc Biol 2008
:
We found that in CB B cells
activation of extracellular signal regulated kinase ( ERK ) and
p38 following ligation of CD40 but not of the
B-cell antigen receptor (BCR) was inefficient
Jiang et al., J Exp Med 1998
:
In contrast,
BCR mediated
p38 MAPK activation was detected in all three PTK-deficient cells, suggesting that no single PTK is essential